Repatha shortage?

I don’t have real-time stock data, but Repatha (evolocumab) has had intermittent shortages in the past due to manufacturing or supply-chain issues. To check current availability:

- FDA Drug Shortages database (US): search for evolocumab or Repatha.
- Amgen’s Repatha site or patient support line for latest supply updates and options.
- Your local pharmacy or pharmacist, who can confirm current stock and any backorder plans.

What to do if there’s a shortage:
- Talk with your prescriber about alternatives or timing (e.g., switch to a different PCSK9 inhibitor if available, or consider other lipid-lowering therapies).
- Possible alternatives to discuss with your doctor:
- Alirocumab (Praluent)
- Ezetimibe (Zetia)
- Bempedoic acid (Nexletol)
- Inclisiran (Leqvio) where available
- Ensure ongoing statin therapy if appropriate, and ask about non-statin options or bridging strategies.
- Check for patient assistance programs or insurance help if cost or access is an issue.

If you tell me your country (and, if US, your state), I can point you to the most relevant official sources for current shortage status. If you’re about to run out or have high cardiovascular risk, contact your clinician promptly for a plan.